At a glance
- Originator Bristol-Myers Squibb
- Class Antivirals; Quinolizines
- Mechanism of Action Influenza virus fusion inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 23 Feb 2001 No-Development-Reported for Influenza virus infections in USA (Unknown route)
- 03 Nov 1998 New profile
- 03 Nov 1998 Preclinical development for Influenza virus infections in USA (Unknown route)